DESAI VEERAL (Chief Strategy & Dev. Officer) sold 27.7% of their position (106.36K shares) of AGILON HEALTH, INC. on the open market
Open‑market sale worth $2.17M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+79.57K
Price / share
$1.00
Trade value
$79.57K
% of position
Common Stock
Shares
−69.82K
Price / share
$20.43
Trade value
$1.43M
% of position
Common Stock
Shares
−9.74K
Price / share
$21.35
Trade value
$207.99K
% of position
Common Stock
Shares
+26.79K
Price / share
$1.00
Trade value
$26.79K
% of position
Common Stock
Shares
−26.79K
Price / share
$20.00
Trade value
$535.78K
% of position
Net shares
+0.00
Net value
-$2.06M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/21/2022 | M · Option Exercise | +79.57K | $1.00 | $79.57K | 28.6% | 278.21K | 357.78K |
| Common Stock Direct | 4/21/2022 | S · Sale | −69.82K | $20.43 | $1.43M | 19.5% | 357.78K | 287.95K |
| Common Stock Direct | 4/21/2022 | S · Sale | −9.74K | $21.35 | $207.99K | 3.4% | 287.95K | 278.21K |
| Common Stock Direct | 4/22/2022 | M · Option Exercise | +26.79K | $1.00 | $26.79K | 9.6% | 278.21K | 305K |
| Common Stock Direct | 4/22/2022 | S · Sale | −26.79K | $20.00 | $535.78K | 8.8% | 305K | 278.21K |
| Total | +0.00 | -$2.06M | ||||||
Options (Rights to Buy)
Common Stock
79.57K shares
Shares
−79.57K
Strike price
1.00
Held after
589.43K
Exercisable
—
Options (Rights to Buy)
Common Stock
26.79K shares
Shares
−26.79K
Strike price
1.00
Held after
562.64K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Options (Rights to Buy) Direct | Common Stock79.57K shares | 4/21/2022 | M · Option Exercise | −79.57K | 1.00 | — | 589.43K |
| Options (Rights to Buy) Direct | Common Stock26.79K shares | 4/22/2022 | M · Option Exercise | −26.79K | 1.00 | — | 562.64K |